MARKET

DXCM

DXCM

Dexcom Inc
NASDAQ
86.68
+0.06
+0.07%
After Hours: 86.68 0 0.00% 19:30 09/28 EDT
OPEN
86.87
PREV CLOSE
86.62
HIGH
87.34
LOW
85.27
VOLUME
3.41M
TURNOVER
--
52 WEEK HIGH
92.59
52 WEEK LOW
54.11
MARKET CAP
32.71B
P/E (TTM)
34.39
1D
5D
1M
3M
1Y
5Y
1D
This Stock Could Be the Big Winner Out of Oura's IPO
Barron‘s · 3h ago
Why DexCom Could Be the Big Winner Out of Oura's IPO
Barron‘s · 3h ago
Dexcom Finds CGM Awareness And Access Challenges In Type 2 Diabetes
NASDAQ · 5h ago
Weekly Report: what happened at DXCM last week (0921-0925)?
Weekly Report · 14h ago
Dexcom Becomes Team Novo Nordisk's Official CGM Partner, Releases Report Citing Three Type 2 Care Challenges Across Eight Countries
Benzinga · 17h ago
Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care
Barchart · 23h ago
Find alpha in the revenue growth fog - Goldman
Seeking Alpha · 1d ago
DexCom (DXCM) Tests Its Execution Story After Expanding Its CFO Role
Simply Wall St · 2d ago
More
About DXCM
DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. It enables people to take control of health through innovative biosensing technology. The G7 is an integrated continuous glucose monitoring system. Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes. The G7 and G7 15 Day includes finger stick elimination, continuous glucose readings and others.

Webull offers DexCom Inc stock information, including NASDAQ: DXCM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DXCM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DXCM stock methods without spending real money on the virtual paper trading platform.